西布曲明

Sibutramine

Abstract

Sibutramine is no longer marketed in the United States. Because there is no published experience with sibutramine during breastfeeding, an alternate therapy may be preferred, especially while nursing a newborn or preterm infant. Information on the effect of sibutramine on serum prolactin is somewhat conflicting.

摘要

西布曲明在美国已不再上市。由于尚无关于西布曲明在母乳喂养期间的公开经验，因此可能更倾向于选择替代疗法，尤其是在哺育新生儿或早产儿期间。关于西布曲明对血清催乳素影响的信息存在一定冲突。